Yuko Okada
Overview
Explore the profile of Yuko Okada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
65
Citations
739
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Masuko N, Tanimura K, Kojima N, Imafuku H, Deguchi M, Okada Y, et al.
J Obstet Gynaecol Res
. 2022 Jan;
48(3):640-646.
PMID: 35052019
Aim: The aim of this prospective cohort study was to evaluate the risk factors for postpartum glucose intolerance (GI) in women with gestational diabetes mellitus (GDM). Method: A total of...
12.
Yokoyama K, Yano T, Kumagai H, Okada Y, Hashimoto Y, Ono S, et al.
Clin J Gastroenterol
. 2022 Jan;
15(1):95-100.
PMID: 35000121
When performing endoscopic reduction in patients with gastric volvulus, it is important to maintain a low level of intragastric pressure and to fix the endoscope in the duodenum. Gel immersion...
13.
Horiguchi M, Okada Y, Turudome Y, Ushijima K
Int J Mol Sci
. 2021 Oct;
22(20).
PMID: 34681566
Type 1 diabetes mellitus is characterized by the destruction of pancreatic β-cells and requires the regeneration of these destroyed pancreatic β-cells for radical treatment. The degeneration of organelles in stem...
14.
Otowa-Suematsu N, Sakaguchi K, Kaneko A, Ito J, Morita Y, Miura H, et al.
J Diabetes Investig
. 2021 Jun;
12(12):2197-2202.
PMID: 34081831
Aims: Whereas homeostasis model assessment of insulin resistance (HOMA-IR), an easily measured but limited index of insulin resistance, has been shown to correlate with impairment of cardiac function in individuals...
15.
Yamada T, Sakaguchi K, Okada Y, Miura H, Otowa-Suematsu N, So A, et al.
Diabetol Int
. 2021 Mar;
12(2):197-206.
PMID: 33786274
Sodium-glucose cotransporter 2 (SGLT2) inhibitors often increase the hematocrit. It remains unclear whether this increase would be observed in all patients administered SGLT2 inhibitors, however. We therefore used the data...
16.
Hashimoto Y, Yokoyama K, Kumagai H, Okada Y, Yamagata T
Clin J Gastroenterol
. 2020 Sep;
13(6):1096-1101.
PMID: 32944796
Juvenile polyposis syndrome (JPS) and hereditary hemorrhagic telangiectasia (HHT) are both relatively rare hereditary disorders. Some patients with the SMAD4 gene mutation develop both JPS and HHT, a condition termed...
17.
Yamada T, Fukuoka H, Hosokawa Y, Odake Y, Yoshida K, Matsumoto R, et al.
BMC Endocr Disord
. 2020 Sep;
20(1):140.
PMID: 32917197
Background: Plasma renin activity (PRA) is generally increased in patients with pheochromocytoma (PCC) due to low circulating plasma volume and activation of β-1 adrenergic receptor signaling. However, there has been...
18.
Miura H, Sakaguchi K, Otowa-Suematsu N, Yamada T, So A, Komada H, et al.
Diabetes Obes Metab
. 2020 Aug;
22(12):2356-2363.
PMID: 32744395
Materials And Methods: In this multicentre, crossover trial, 46 individuals with type 1 diabetes and essentially undetectable circulating C-peptide were randomly assigned to either the IDeg-first/IGlarU300-second group or the IGlarU300-first/IDeg-second...
19.
Morita Y, Nogami M, Sakaguchi K, Okada Y, Hirota Y, Sugawara K, et al.
Diabetes Care
. 2020 Jun;
43(8):1796-1802.
PMID: 32493754
Objective: Positron emission tomography (PET)-computed tomography has revealed that metformin promotes the intestinal accumulation of [F]fluorodeoxyglucose (FDG), a nonmetabolizable glucose derivative. It has remained unknown, however, whether this accumulation occurs...
20.
So A, Sakaguchi K, Okada Y, Morita Y, Yamada T, Miura H, et al.
Endocr J
. 2020 Feb;
67(5):501-507.
PMID: 32023587
We had aimed to determine whether homeostasis model assessment-insulin resistance (HOMA-IR) reflects insulin resistance-sensitivity during treatment with a sodium-glucose cotransporter 2 inhibitor (SGLT2i). Hyperinsulinemic-euglycemic clamp analysis was performed in 22...